2Walport MJ.Complement and systemic lupus erythematosus[J].Arthritis Res,2002,4:279.
3Graham RR,Ortmann W,Rodine P,et al.Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE[J].Eur J Hum Genet,2007,15:823.
4Wang Q,Ye D,Yin J,et al.Programmed cell death 1 genotypes are associated with susceptibility to systemic lupus erythematosus among Chinese[J].Arch Dermatol Res,2008,300:91.
5Munoz LE,Gaipl US,Franz S,et al.SLE-a disease of clearance deficiency[J].Rheumatology (Oxford),2005,44:1101.
6Karassa FB,Trikalinos TA,Ioannidis JP.Role of the Fcgamma receptor Ⅱa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis:a meta-analysis[J].Arthritis Rheum,2002,46:1563.
7Karassa FB,Bijl M,Davies KA,et al.Role of the Fcgamma receptor ⅡA polymorphism in the antiphospholipid syndrome:an international meta-analysis[J].Arthritis Rheum,2005,48:1930.
8Karassa FB,Trikalinos TA,Ioannidis JP.The Fc gamma RⅢA-F158 allele is a risk factor for the development of lupus nephritis:a meta-analysis[J].Kidney Int,2005,63:1475.
9Zuniga R,Markowitz GS,Arkachaisri T,et al.Identification of IgG subclasses and C-reactive protein in lupus nephritis:the relationship between the composition of immune deposits and FCgamma receptor type ⅡA alleles[J].Arthritis Rheum,2006,48:460.
